PD39-04 EVALUATION OF TESTICULAR TOXICITY WITH THE NOVEL EPIGENOME THERAPEUTIC AGENT NCL1

INTRODUCTION AND OBJECTIVE:Recent studies have shown that epigenetic alterations, such as lysine-specific demethylase 1 (LSD1), lead to oncogenic activation, suggesting alterations in therapeutic t...